ArticleAsian Pacific journal of cancer prevention : APJCP2022

Conjugation of Cetuximab - Puromycin and Its Target-Specific Effect on Triple Negative Breast Cancer Cell Lines.

Diah Puspitasari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.